▶ 調査レポート

美容整形用注射の世界市場レポート2020

• 英文タイトル:Global Injectable for Cosmetic Surgery Sales Market Report 2020

QYResearchが調査・発行した産業分析レポートです。美容整形用注射の世界市場レポート2020 / Global Injectable for Cosmetic Surgery Sales Market Report 2020 / QY20ST-06854資料のイメージです。• レポートコード:QY20ST-06854
• 出版社/出版日:QYResearch / 2020年9月25日
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、145ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥580,000 (USD4,000)▷ お問い合わせ
  Multi User¥870,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,160,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の美容整形用注射市場について種類別(ボツリヌス毒素、軟組織充填剤、皮膚充填剤、レーザー、その他)、用途別(病院、皮膚科クリニック、美容センター、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・美容整形用注射市場の概要
・世界の主要地域別美容整形用注射市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の美容整形用注射市場規模2015-2026:種類別(ボツリヌス毒素、軟組織充填剤、皮膚充填剤、レーザー、その他)
・世界の美容整形用注射市場規模2015-2026:用途別(病院、皮膚科クリニック、美容センター、その他)
・美容整形用注射の北米市場規模2015-2020
・美容整形用注射のヨーロッパ市場規模2015-2020
・美容整形用注射の中国市場規模2015-2020
・美容整形用注射の日本市場規模2015-2020
・美容整形用注射の東南アジア市場規模2015-2020
・美容整形用注射のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・美容整形用注射の製造コスト分析
・販売チャネル、流通業者、顧客
・美容整形用注射の市場動向・機会・課題
・調査の結論

A recently published report by QY Research titled Global Injectable for Cosmetic Surgery Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Injectable for Cosmetic Surgery market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Cosmetic surgery is a process that enhances or alters a portion of an individual’s body, or, face through incision. Cosmetic surgeries include reconstruction or reshaping of body parts, altering facial structure (maxillofacial), altering structure of jaw (craniofacial), etc. People from urban areas constitute the largest patient base for cosmetic surgeries due to increased aesthetic appeal.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Injectable for Cosmetic Surgery market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Injectable for Cosmetic Surgery industry.
Based on our recent survey, we have several different scenarios about the Injectable for Cosmetic Surgery YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Injectable for Cosmetic Surgery will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Injectable for Cosmetic Surgery market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Injectable for Cosmetic Surgery market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Injectable for Cosmetic Surgery market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Injectable for Cosmetic Surgery market. The report also includes nautical information, where it shows Injectable for Cosmetic Surgery market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Injectable for Cosmetic Surgery market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Injectable for Cosmetic Surgery market.
Geographical Analysis:
Based on region, the global Injectable for Cosmetic Surgery market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Injectable for Cosmetic Surgery market are
Allergan
Mentor
Candela
Cutera
Lumenis
Palomar Medical
Iridex
Solta Medical
DermaMed Pharma
Medtronic
Johnson & Johnson
Syneron Medical
Cynosure
Segment by Type
Botulinum Toxin
Soft Tissue Fillers
Dermal Fillers
Lasers
Others
Segment by Application
Hospitals
Dermatology Clinics
Beauty Centers
Othes
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Injectable for Cosmetic Surgery market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Injectable for Cosmetic Surgery market.
• The market share of the global Injectable for Cosmetic Surgery market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Injectable for Cosmetic Surgery market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Injectable for Cosmetic Surgery market.

レポート目次

1 Injectable for Cosmetic Surgery Market Overview
1.1 Injectable for Cosmetic Surgery Product Scope
1.2 Injectable for Cosmetic Surgery Segment by Type
1.2.1 Global Injectable for Cosmetic Surgery Sales by Type (2020-2026)
1.2.2 Botulinum Toxin
1.2.3 Soft Tissue Fillers
1.2.4 Dermal Fillers
1.2.5 Lasers
1.2.6 Others
1.3 Injectable for Cosmetic Surgery Segment by Application
1.3.1 Global Injectable for Cosmetic Surgery Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Dermatology Clinics
1.3.4 Beauty Centers
1.3.5 Othes
1.4 Injectable for Cosmetic Surgery Market Estimates and Forecasts (2015-2026)
1.4.1 Global Injectable for Cosmetic Surgery Sales Growth Rate (2015-2026)
1.4.2 Global Injectable for Cosmetic Surgery Revenue and Growth Rate (2015-2026)
1.4.3 Global Injectable for Cosmetic Surgery Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Injectable for Cosmetic Surgery Industry Impact
1.5.1 How the Covid-19 is Affecting the Injectable for Cosmetic Surgery Industry
1.5.1.1 Injectable for Cosmetic Surgery Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Injectable for Cosmetic Surgery Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Injectable for Cosmetic Surgery Players to Combat Covid-19 Impact

2 Injectable for Cosmetic Surgery Estimate and Forecast by Region
2.1 Global Injectable for Cosmetic Surgery Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Injectable for Cosmetic Surgery Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Injectable for Cosmetic Surgery Sales Market Share by Region (2015-2020)
2.2.2 Global Injectable for Cosmetic Surgery Revenue Market Share by Region (2015-2020)
2.3 Global Injectable for Cosmetic Surgery Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Injectable for Cosmetic Surgery Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Injectable for Cosmetic Surgery Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
2.4.2 Europe Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
2.4.3 China Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
2.4.4 Japan Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
2.4.6 India Injectable for Cosmetic Surgery Estimates and Projections (2015-2026)
3 Global Injectable for Cosmetic Surgery Competition Landscape by Players
3.1 Global Top Injectable for Cosmetic Surgery Players by Sales (2015-2020)
3.2 Global Top Injectable for Cosmetic Surgery Players by Revenue (2015-2020)
3.3 Global Injectable for Cosmetic Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable for Cosmetic Surgery as of 2019)
3.4 Global Injectable for Cosmetic Surgery Average Price by Company (2015-2020)
3.5 Manufacturers Injectable for Cosmetic Surgery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Injectable for Cosmetic Surgery Players (Opinion Leaders)
4 Global Injectable for Cosmetic Surgery Market Size by Type
4.1 Global Injectable for Cosmetic Surgery Historic Market Review by Type (2015-2020)
4.1.1 Global Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
4.1.2 Global Injectable for Cosmetic Surgery Revenue Market Share by Type (2015-2020)
4.1.3 Global Injectable for Cosmetic Surgery Price by Type (2014-2020)
4.2 Global Injectable for Cosmetic Surgery Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Injectable for Cosmetic Surgery Sales Forecast by Type (2021-2026)
4.2.2 Global Injectable for Cosmetic Surgery Revenue Forecast by Type (2021-2026)
4.2.3 Global Injectable for Cosmetic Surgery Price Forecast by Type (2021-2026)
5 Global Injectable for Cosmetic Surgery Market Size by Application
5.1 Global Injectable for Cosmetic Surgery Historic Market Review by Application (2015-2020)
5.1.1 Global Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
5.1.2 Global Injectable for Cosmetic Surgery Revenue Market Share by Application (2015-2020)
5.1.3 Global Injectable for Cosmetic Surgery Price by Application (2015-2020)
5.2 Global Injectable for Cosmetic Surgery Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Injectable for Cosmetic Surgery Sales Forecast by Application (2021-2026)
5.2.2 Global Injectable for Cosmetic Surgery Revenue Forecast by Application (2021-2026)
5.2.3 Global Injectable for Cosmetic Surgery Price Forecast by Application (2021-2026)

3 North America Injectable for Cosmetic Surgery Market Facts & Figures
3.2 North America Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
3.3 North America Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
3.4 North America Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

4 Europe Injectable for Cosmetic Surgery Market Facts & Figures
4.2 Europe Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
4.3 Europe Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
4.4 Europe Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

5 China Injectable for Cosmetic Surgery Market Facts & Figures
5.2 China Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
5.3 China Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
5.4 China Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

6 Japan Injectable for Cosmetic Surgery Market Facts & Figures
6.2 Japan Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
6.3 Japan Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
6.4 Japan Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

7 Southeast Asia Injectable for Cosmetic Surgery Market Facts & Figures
7.2 Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

8 India Injectable for Cosmetic Surgery Market Facts & Figures
8.2 India Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
8.3 India Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
8.4 India Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Injectable for Cosmetic Surgery Business
12.1 Allergan
12.1.1 Allergan Injectable for Cosmetic Surgery Corporation Information
12.1.2 Allergan Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.1.3 Allergan Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Allergan Injectable for Cosmetic Surgery Products Offered
12.1.5 Allergan Recent Development
12.2 Mentor
12.2.1 Mentor Injectable for Cosmetic Surgery Corporation Information
12.2.2 Mentor Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.2.3 Mentor Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Mentor Injectable for Cosmetic Surgery Products Offered
12.2.5 Mentor Recent Development
12.3 Candela
12.3.1 Candela Injectable for Cosmetic Surgery Corporation Information
12.3.2 Candela Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.3.3 Candela Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Candela Injectable for Cosmetic Surgery Products Offered
12.3.5 Candela Recent Development
12.4 Cutera
12.4.1 Cutera Injectable for Cosmetic Surgery Corporation Information
12.4.2 Cutera Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.4.3 Cutera Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cutera Injectable for Cosmetic Surgery Products Offered
12.4.5 Cutera Recent Development
12.5 Lumenis
12.5.1 Lumenis Injectable for Cosmetic Surgery Corporation Information
12.5.2 Lumenis Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.5.3 Lumenis Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lumenis Injectable for Cosmetic Surgery Products Offered
12.5.5 Lumenis Recent Development
12.6 Palomar Medical
12.6.1 Palomar Medical Injectable for Cosmetic Surgery Corporation Information
12.6.2 Palomar Medical Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.6.3 Palomar Medical Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Palomar Medical Injectable for Cosmetic Surgery Products Offered
12.6.5 Palomar Medical Recent Development
12.7 Iridex
12.7.1 Iridex Injectable for Cosmetic Surgery Corporation Information
12.7.2 Iridex Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.7.3 Iridex Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Iridex Injectable for Cosmetic Surgery Products Offered
12.7.5 Iridex Recent Development
12.8 Solta Medical
12.8.1 Solta Medical Injectable for Cosmetic Surgery Corporation Information
12.8.2 Solta Medical Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.8.3 Solta Medical Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Solta Medical Injectable for Cosmetic Surgery Products Offered
12.8.5 Solta Medical Recent Development
12.9 DermaMed Pharma
12.9.1 DermaMed Pharma Injectable for Cosmetic Surgery Corporation Information
12.9.2 DermaMed Pharma Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.9.3 DermaMed Pharma Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.9.4 DermaMed Pharma Injectable for Cosmetic Surgery Products Offered
12.9.5 DermaMed Pharma Recent Development
12.10 Medtronic
12.10.1 Medtronic Injectable for Cosmetic Surgery Corporation Information
12.10.2 Medtronic Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.10.3 Medtronic Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Medtronic Injectable for Cosmetic Surgery Products Offered
12.10.5 Medtronic Recent Development
12.11 Johnson & Johnson
12.11.1 Johnson & Johnson Injectable for Cosmetic Surgery Corporation Information
12.11.2 Johnson & Johnson Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.11.3 Johnson & Johnson Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Johnson & Johnson Injectable for Cosmetic Surgery Products Offered
12.11.5 Johnson & Johnson Recent Development
12.12 Syneron Medical
12.12.1 Syneron Medical Injectable for Cosmetic Surgery Corporation Information
12.12.2 Syneron Medical Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.12.3 Syneron Medical Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Syneron Medical Injectable for Cosmetic Surgery Products Offered
12.12.5 Syneron Medical Recent Development
12.13 Cynosure
12.13.1 Cynosure Injectable for Cosmetic Surgery Corporation Information
12.13.2 Cynosure Injectable for Cosmetic Surgery Business Overview and Total Revenue
12.13.3 Cynosure Injectable for Cosmetic Surgery Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Cynosure Injectable for Cosmetic Surgery Products Offered
12.13.5 Cynosure Recent Development

13 Injectable for Cosmetic Surgery Manufacturing Cost Analysis
13.1 Injectable for Cosmetic Surgery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Injectable for Cosmetic Surgery
13.4 Injectable for Cosmetic Surgery Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Injectable for Cosmetic Surgery Distributors List
14.3 Injectable for Cosmetic Surgery Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Injectable for Cosmetic Surgery Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Injectable for Cosmetic Surgery Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Injectable for Cosmetic Surgery Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Injectable for Cosmetic Surgery Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Injectable for Cosmetic Surgery Players to Combat Covid-19 Impact
Table 8. Global Market Injectable for Cosmetic Surgery Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Injectable for Cosmetic Surgery Sales (K Units) by Region (2015-2020)
Table 10. Global Injectable for Cosmetic Surgery Sales Market Share by Region (2015-2020)
Table 11. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Injectable for Cosmetic Surgery Revenue Share by Region (2015-2020)
Table 13. Global Injectable for Cosmetic Surgery Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Injectable for Cosmetic Surgery Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Injectable for Cosmetic Surgery Revenue Share Forecast by Region (2021-2026)
Table 17. Global Injectable for Cosmetic Surgery (K Units) of Key Companies (2015-2020)
Table 18. Global Injectable for Cosmetic Surgery Sales Share by Company (2015-2020)
Table 19. Global Injectable for Cosmetic Surgery Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Injectable for Cosmetic Surgery Revenue Share by Company (2015-2020)
Table 21. Global Injectable for Cosmetic Surgery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable for Cosmetic Surgery as of 2019)
Table 22. Global Injectable for Cosmetic Surgery Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Injectable for Cosmetic Surgery Manufacturing Sites and Area Served
Table 24. Manufacturers Injectable for Cosmetic Surgery Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Injectable for Cosmetic Surgery Players
Table 27. Global Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 28. Global Injectable for Cosmetic Surgery Sales Share by Type (2015-2020)
Table 29. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Injectable for Cosmetic Surgery Price (K Units) by Type (2015-2020)
Table 31. Global Injectable for Cosmetic Surgery Sales Share by Type (2021-2026)
Table 32. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Injectable for Cosmetic Surgery Revenue Share by Type (2021-2026)
Table 34. Global Injectable for Cosmetic Surgery Price (K Units) by Type (2021-2026)
Table 35. Global Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 36. Global Injectable for Cosmetic Surgery Sales Share by Application (2015-2020)
Table 37. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Injectable for Cosmetic Surgery Price (K Units) by Application (2015-2020)
Table 39. Global Injectable for Cosmetic Surgery Sales (K Units) by Application (2021-2026)
Table 40. Global Injectable for Cosmetic Surgery Sales Share by Application (2021-2026)
Table 41. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Injectable for Cosmetic Surgery Revenue Share by Application (2021-2026)
Table 43. Global Injectable for Cosmetic Surgery Price (K Units) by Application (2021-2026)
Table 44. United States Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 45. United States Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 46. United States Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 47. United States Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 48. United States Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 49. United States Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
Table 50. Europe Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 51. Europe Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 52. Europe Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 53. Europe Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 54. Europe Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 55. Europe Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 56. China Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 57. China Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 58. China Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 59. China Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 60. China Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 61. China Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
Table 62. Japan Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 63. Japan Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 64. Japan Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 65. Japan Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 66. Japan Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 67. Japan Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
Table 74. India Injectable for Cosmetic Surgery Sales (K Units) by Company (2015-2020)
Table 75. India Injectable for Cosmetic Surgery Sales Market Share by Company (2015-2020)
Table 76. India Injectable for Cosmetic Surgery Sales (K Units) by Type (2015-2020)
Table 77. India Injectable for Cosmetic Surgery Sales Market Share by Type (2015-2020)
Table 78. India Injectable for Cosmetic Surgery Sales (K Units) by Application (2015-2020)
Table 79. India Injectable for Cosmetic Surgery Sales Market Share by Application (2015-2020)
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Allergan Injectable for Cosmetic Surgery Product
Table 84. Allergan Recent Development
Table 85. Mentor Corporation Information
Table 86. Mentor Description and Business Overview
Table 87. Mentor Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Mentor Injectable for Cosmetic Surgery Product
Table 89. Mentor Recent Development
Table 90. Candela Corporation Information
Table 91. Candela Description and Business Overview
Table 92. Candela Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Candela Injectable for Cosmetic Surgery Product
Table 94. Candela Recent Development
Table 95. Cutera Corporation Information
Table 96. Cutera Description and Business Overview
Table 97. Cutera Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cutera Injectable for Cosmetic Surgery Product
Table 99. Cutera Recent Development
Table 100. Lumenis Corporation Information
Table 101. Lumenis Description and Business Overview
Table 102. Lumenis Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Lumenis Injectable for Cosmetic Surgery Product
Table 104. Lumenis Recent Development
Table 105. Palomar Medical Corporation Information
Table 106. Palomar Medical Description and Business Overview
Table 107. Palomar Medical Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Palomar Medical Injectable for Cosmetic Surgery Product
Table 109. Palomar Medical Recent Development
Table 110. Iridex Corporation Information
Table 111. Iridex Description and Business Overview
Table 112. Iridex Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Iridex Injectable for Cosmetic Surgery Product
Table 114. Iridex Recent Development
Table 115. Solta Medical Corporation Information
Table 116. Solta Medical Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Solta Medical Description and Business Overview
Table 118. Solta Medical Injectable for Cosmetic Surgery Product
Table 119. Solta Medical Recent Development
Table 120. DermaMed Pharma Corporation Information
Table 121. DermaMed Pharma Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. DermaMed Pharma Description and Business Overview
Table 123. DermaMed Pharma Injectable for Cosmetic Surgery Product
Table 124. DermaMed Pharma Recent Development
Table 125. Medtronic Corporation Information
Table 126. Medtronic Description and Business Overview
Table 127. Medtronic Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Medtronic Injectable for Cosmetic Surgery Product
Table 129. Medtronic Recent Development
Table 130. Johnson & Johnson Corporation Information
Table 131. Johnson & Johnson Description and Business Overview
Table 132. Johnson & Johnson Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Johnson & Johnson Injectable for Cosmetic Surgery Product
Table 134. Johnson & Johnson Recent Development
Table 135. Syneron Medical Corporation Information
Table 136. Syneron Medical Description and Business Overview
Table 137. Syneron Medical Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Syneron Medical Injectable for Cosmetic Surgery Product
Table 139. Syneron Medical Recent Development
Table . Cynosure Corporation Information
Table . Cynosure Description and Business Overview
Table . Cynosure Injectable for Cosmetic Surgery Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Cynosure Injectable for Cosmetic Surgery Product
Table . Cynosure Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Injectable for Cosmetic Surgery Distributors List
Table 148. Injectable for Cosmetic Surgery Customers List
Table 149. Market Key Trends
Table 150. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 151. Key Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Injectable for Cosmetic Surgery Product Picture
Figure 2. Global Injectable for Cosmetic Surgery Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Injectable for Cosmetic Surgery Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Dermatology Clinics Examples
Figure 8. Beauty Centers Examples
Figure 9. Othes Examples
Figure 10. Global Injectable for Cosmetic Surgery Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Injectable for Cosmetic Surgery Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Injectable for Cosmetic Surgery Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Injectable for Cosmetic Surgery Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Injectable for Cosmetic Surgery Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Injectable for Cosmetic Surgery Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Injectable for Cosmetic Surgery Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Injectable for Cosmetic Surgery Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Injectable for Cosmetic Surgery Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Injectable for Cosmetic Surgery Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Injectable for Cosmetic Surgery Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Injectable for Cosmetic Surgery Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Injectable for Cosmetic Surgery Players Market Share by Revenue in Injectable for Cosmetic Surgery 2015 & 2019
Figure 28. Injectable for Cosmetic Surgery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Injectable for Cosmetic Surgery Revenue Share by Type (2015-2020)
Figure 30. Global Injectable for Cosmetic Surgery Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Injectable for Cosmetic Surgery Revenue Share by Application (2015-2020)
Figure 32. Global Injectable for Cosmetic Surgery Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 34. United States Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 35. Europe Injectable for Cosmetic Surgery Sales Market Share by Company in 2019
Figure 36. Europe Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 37. Europe Injectable for Cosmetic Surgery Sales Market Share by Application in 2019
Figure 38. China Injectable for Cosmetic Surgery Sales Market Share by Company in 2019
Figure 39. China Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 40. China Injectable for Cosmetic Surgery Sales Market Share by Application in 2019
Figure 41. Japan Injectable for Cosmetic Surgery Sales Market Share by Company in 2019
Figure 42. Japan Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 43. Japan Injectable for Cosmetic Surgery Sales Market Share by Application in 2019
Figure 44. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Company in 2019
Figure 45. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 46. Southeast Asia Injectable for Cosmetic Surgery Sales Market Share by Application in 2019
Figure 47. India Injectable for Cosmetic Surgery Sales Market Share by Company in 2019
Figure 48. India Injectable for Cosmetic Surgery Sales Market Share by Type in 2019
Figure 49. India Injectable for Cosmetic Surgery Sales Market Share by Application in 2019
Figure 50. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mentor Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Candela Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Cutera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Lumenis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Palomar Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Iridex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Solta Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. DermaMed Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Syneron Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Cynosure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Key Raw Materials Price Trend
Figure 64. Manufacturing Cost Structure of Injectable for Cosmetic Surgery
Figure 65. Manufacturing Process Analysis of Injectable for Cosmetic Surgery
Figure 66. Injectable for Cosmetic Surgery Industrial Chain Analysis
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 69. Porter's Five Forces Analysis
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed